Patrick Decker - Nov 14, 2023 Form 4 Insider Report for Xylem Inc. (XYL)

Role
President & CEO, Director
Signature
/s/ Callie Plant, by power of attorney for Patrick K. Decker
Stock symbol
XYL
Transactions as of
Nov 14, 2023
Transactions value $
-$6,465,404
Form type
4
Date filed
11/16/2023, 05:22 PM
Previous filing
Jul 6, 2023
Next filing
Jan 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XYL Common Stock Options Exercise $3.58M +99.6K +34.65% $35.96 387K Nov 14, 2023 Direct
transaction XYL Common Stock Sale -$5.07M -50.5K -13.03% $100.57 337K Nov 14, 2023 Direct F1, F2
transaction XYL Common Stock Sale -$4.97M -49.2K -14.61% $101.13 288K Nov 14, 2023 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XYL Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -99.6K -100% $0.00* 0 Nov 14, 2023 Common Stock 99.6K $35.96 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2023.
F2 This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $100.04 to $101.035. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
F3 This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $101.04 to $101.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
F4 The February 24, 2015 option grant vested one-third on February 24, 2016, February 24, 2017 and February 24, 2018.